In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
In the latest session, Alector Inc (NASDAQ: ALEC) closed at $5.07 down -4.52% from its previous closing price of $5.31. In other words, the price has decreased by -$4.52 from its previous closing price. On the day, 0.56 million shares were traded. ALEC stock price reached its highest trading level at $5.33 during the session, while it also had its lowest trading level at $5.06.
Ratios:
For a deeper understanding of Alector Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.18 and its Current Ratio is at 3.18. In the meantime, Its Debt-to-Equity ratio is 0.29 whereas as Long-Term Debt/Eq ratio is at 0.23.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Stifel on December 14, 2023, Upgraded its rating to Buy and sets its target price to $15 from $8 previously.
On December 12, 2023, Deutsche Bank started tracking the stock assigning a Buy rating and target price of $12.
On September 25, 2023, Goldman started tracking the stock assigning a Sell rating and target price of $4.Goldman initiated its Sell rating on September 25, 2023, with a $4 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 04 ’24 when Rosenthal Arnon sold 18,837 shares for $6.92 per share. The transaction valued at 130,386 led to the insider holds 2,000,380 shares of the business.
Kenkare-Mitra Sara sold 10,169 shares of ALEC for $70,387 on Mar 04 ’24. The President and Head of R&D now owns 318,847 shares after completing the transaction at $6.92 per share. On Mar 04 ’24, another insider, Romano Gary, who serves as the Chief Medical Officer of the company, sold 6,001 shares for $6.92 each. As a result, the insider received 41,554 and left with 196,313 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALEC now has a Market Capitalization of 485448960 and an Enterprise Value of -24494256. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.00 while its Price-to-Book (P/B) ratio in mrq is 3.21. Its current Enterprise Value per Revenue stands at -0.252 whereas that against EBITDA is 0.168.
Stock Price History:
The Beta on a monthly basis for ALEC is 0.81, which has changed by -0.22831053 over the last 52 weeks, in comparison to a change of 0.2160933 over the same period for the S&P500. Over the past 52 weeks, ALEC has reached a high of $9.06, while it has fallen to a 52-week low of $3.66. The 50-Day Moving Average of the stock is -18.91%, while the 200-Day Moving Average is calculated to be -19.29%.
Shares Statistics:
For the past three months, ALEC has traded an average of 728.80K shares per day and 756510 over the past ten days. A total of 84.88M shares are outstanding, with a floating share count of 72.80M. Insiders hold about 23.96% of the company’s shares, while institutions hold 65.53% stake in the company. Shares short for ALEC as of 1711584000 were 6468719 with a Short Ratio of 8.88, compared to 1709164800 on 5385012. Therefore, it implies a Short% of Shares Outstanding of 6468719 and a Short% of Float of 8.61.
Earnings Estimates
The stock of Alector Inc (ALEC) is currently being evaluated by 9 analysts who are actively contributing to its market rating.On average, analysts expect EPS of -$0.51 for the current quarter, with a high estimate of -$0.34 and a low estimate of -$0.64, while EPS last year was -$0.55. The consensus estimate for the next quarter is -$0.53, with high estimates of -$0.39 and low estimates of -$0.64.
Analysts are recommending an EPS of between -$1.53 and -$2.33 for the fiscal current year, implying an average EPS of -$2.1. EPS for the following year is -$1.77, with 8 analysts recommending between -$0.43 and -$2.56.
Revenue Estimates
A total of 6 analysts believe the company’s revenue will be $14.8M this quarter.It ranges from a high estimate of $16.3M to a low estimate of $10M. As of the current estimate, Alector Inc’s year-ago sales were $16.55M, an estimated decrease of -10.60% from the year-ago figure. For the next quarter, 6 analysts are estimating revenue of $14.8M, a decrease of -73.70% less than the figure of -$10.60% in the same quarter last year. There is a high estimate of $16.3M for the next quarter, whereas the lowest estimate is $10M.
A total of 10 analysts have provided revenue estimates for ALEC’s current fiscal year. The highest revenue estimate was $65M, while the lowest revenue estimate was $50M, resulting in an average revenue estimate of $61.58M. In the same quarter a year ago, actual revenue was $97.06M, down -36.60% from the average estimate. Based on 9 analysts’ estimates, the company’s revenue will be $116.24M in the next fiscal year. The high estimate is $250M and the low estimate is $42.84M. The average revenue growth estimate for next year is up 88.80% from the average revenue estimate for this year.
